Edge Capital Group, LLC Abb Vie Inc. Transaction History

Edge Capital Group, LLC

$2.21 Billion
Q3 2024

A detailed history of Edge Capital Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Edge Capital Group, LLC holds 4,198 shares of ABBV stock, worth $742,836. This represents 0.04% of its overall portfolio holdings.

Number of Shares

4,198

Previous 3,948 6.33%

Holding current value

$742,836

Previous $677,000 22.45%

% of portfolio

0.04%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $40,960 - $49,832	250 Added 6.33%	4,198 $829,000
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $42,722 - $49,889	-276 Reduced 6.53%	3,948 $677,000
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $14,703 - $16,753	-92 Reduced 2.13%	4,224 $769,000
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $53,388 - $60,128	-388 Reduced 8.25%	4,316 $668,000
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $54,103 - $62,633	-405 Reduced 7.93%	4,704 $701,000
Q2 2023 Aug 08, 2023	SELL	$132.51 - $164.9 $51,148 - $63,651	-386 Reduced 7.02%	5,109 $688,000
Q1 2023 May 04, 2023	BUY	$144.61 - $166.54 $2,458 - $2,831	17 Added 0.31%	5,495 $875,000
Q4 2022 Feb 07, 2023	BUY	$138.31 - $165.87 $8,575 - $10,283	62 Added 1.14%	5,478 $885,000
Q3 2022 Nov 09, 2022	SELL	$134.21 - $153.93 $402 - $461	-3 Reduced 0.06%	5,416 $727,000
Q2 2022 Aug 08, 2022	BUY	$137.62 - $174.96 $60,552 - $76,982	440 Added 8.84%	5,419 $830,000
Q1 2022 May 03, 2022	SELL	$131.98 - $163.75 $67,045 - $83,185	-508 Reduced 9.26%	4,979 $807,000
Q4 2021 Jan 19, 2022	BUY	$107.43 - $135.93 $33,410 - $42,274	311 Added 6.01%	5,487 $743,000
Q3 2021 Oct 26, 2021	SELL	$106.4 - $120.78 $2,766 - $3,140	-26 Reduced 0.5%	5,176 $558,000
Q2 2021 Aug 09, 2021	SELL	$105.21 - $117.21 $20,831 - $23,207	-198 Reduced 3.67%	5,202 $586,000
Q1 2021 May 13, 2021	SELL	$102.3 - $112.62 $964,382 - $1.06 Million	-9,427 Reduced 63.58%	5,400 $584,000
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $766,989 - $1.04 Million	9,529 Added 179.86%	14,827 $1.6 Million
Q3 2020 Nov 09, 2020	BUY	$85.91 - $100.83 $63,917 - $75,017	744 Added 16.34%	5,298 $464,000
Q2 2020 Aug 11, 2020	SELL	$73.37 - $98.18 $26,119 - $34,952	-356 Reduced 7.25%	4,554 $447,000
Q1 2020 May 08, 2020	SELL	$64.5 - $97.79 $23,800 - $36,084	-369 Reduced 6.99%	4,910 $374,000
Q4 2019 Feb 11, 2020	BUY	$72.13 - $90.25 $32,819 - $41,063	455 Added 9.43%	5,279 $467,000
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $96,989 - $116,608	-1,540 Reduced 24.2%	4,824 $365,000
Q2 2019 Jul 25, 2019	BUY	$65.7 - $83.98 $21,024 - $26,873	320 Added 5.29%	6,364 $463,000
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $206,349 - $242,863	-2,675 Reduced 30.68%	6,044 $487,000
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $678,774 - $837,111	8,719 New	8,719 $804,000

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edge Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edge Capital Group, LLC with notifications on news.

Account

Edge Capital Group, LLC Abb Vie Inc. Transaction History